Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barre syndrome

Muscle and Nerve

Volumn 20, Issue 4, 1997, Pages 446-452

  Jacobs, Bart C ^a   Meulstee, Jan ^a   Van Doorn, Pieter A ^a   Van Der Meché, Frans G A ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

antibodies; electrodiagnosis; GM1; GQ1b; Guillain Barre syndrome

Indexed keywords

ANTIBODY; GANGLIOSIDE GM1;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; ELECTRODIAGNOSIS; ELECTROMYOGRAM; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MEDIAN NERVE; MOTOR NERVE; MUSCLE ACTION POTENTIAL; NERVE FIBER DEGENERATION; NERVE INJURY; PRIORITY JOURNAL; SENSORY NERVE; ULNAR NERVE;

ANIMALS; AUTOANTIBODIES; ELECTROMYOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; G(M1) GANGLIOSIDE; GANGLIOSIDES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEDIAN NERVE; MICE; MOTOR NEURONS; MUSCLE, SKELETAL; NERVE GROWTH FACTORS; NEURAL CONDUCTION; NEURONS, AFFERENT; POLYRADICULONEUROPATHY; ULNAR NERVE;

EID: 0030938042     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199704)20:4<446::AID-MUS7>3.0.CO;2-A     Document Type: Article

References (13)

1. Asbury AK, Cornblath DR: Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-S24.
2. Buchwald B, Weishaupt A, Toyka KV, Dudel J: Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci Lett 1995;201:163-166.
3. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I: Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-1917.
4. Corbo M, Quattrini A, Lugaresi A, Santoro M, Latov N, Hays AP: Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons. Ann Neurol 1992;32:487-193.
5. Fross RD, Daube JR: Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987;37:1493-1498.
6. Hakomori S: Glycosphingolipids in cellular interaction, differentiation and oncogenesis. Annu Rev Biochem 1981;50:733-764.
7. Honovar M, Tharakan JKJ, Hughes RAC, Leibowitz S, Winer JB:A clinicopathological study of the Guillain-Barré syndrome. Brain 1991;114:1245-1269.
8. Jacobs BC, Endtz HP, ran der Meché FGA, Hazenberg MP, Achtereekte HAM, van Doom PA: Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol 1995;37:260-264.
9. Jacobs BC, ran Doorn PA, Schmitz PIM, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkaas H, ran der Meché FGA: Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol 1996;40:181-187.
10. Meulstee J, ran der Meché FGA, the Dutch Guillain-Barré Study Group: Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1995;59:482-486.
11. Ogawa-Goto K, Funamoto N, Abe T, Nagashima K: Different ceramide compositions of gangliosides between human motor and sensory nerves. J Neurochem 1990;55:1486-1493.
12. Ogawa-Goto K, Funamoto N, Ohta Y, Abe T, Nagashima K: Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J Neurochem 1992;59:1844-1849.
13. Rees JH, Gregson NA, Hughes RAC: Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816.